Find similar content

Source channel @githubtrending · Post #14848 · Jun 21

#typescript#blockchain#dapps#debugging#ethereum#javascript#smart_contracts#solidity#task_runner#tooling#typescript Hardhat is a powerful Ethereum development tool that helps you write, test, and deploy smart contracts easily and efficiently. It includes a local Ethereum network for testing without real money, advanced debugging tools to find and fix errors quickly, and a flexible plugin system to add extra features. This makes your development faster, safer, and more convenient, especially if you want to build decentralized applications. You can install it with npm, follow simple setup steps, and access many guides and plugins to customize your workflow. Hardhat is widely used by professionals to streamline Ethereum programming and improve code quality. https://github.com/NomicFoundation/hardhat

Hashtags

#typescript #blockchain #dapps #debugging #ethereum #javascript #smart_contracts #solidity #task_runner #tooling

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment